<unk>  is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include nasopharyngitis, headache and upper respiratory tract infection.
Alogliptin
Vildagliptin
Linagliptin
Sitagliptin
Saxagliptin
Gemigliptin
Liraglutide
Pioglitazone